Clinical Trials · NCT00258193
Phase 2 Study of MD-1100 Acetate on Gastrointestinal Transit in Patients With C-IBS
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Ironwood Pharmaceuticals, Inc.
- Enrollment
- 36
- Start date
- Jan 2006
- Locations
- 1 site, United States
- Primary endpoint
- (Safety) AEs to be collected beginning with patient's first administration of study medication through final study visit